Liberia Profile Updated

August 18, 2023

The Liberia profile in ClinRegs has been reviewed and updated as follows:

  • Reorganization of the information included in Scope of Assessment, Risk & Quality Management, and Required Elements
  • Addition of Atlantic Center for Research and Evaluation Institutional Review Board (ACRE IRB) post-approval protocol monitoring procedures (See Scope of Review)
  • Revision of ACRE IRB safety reporting contact information (See Safety Reporting)
  • Clarification of clinical trial insurance and indemnification certificate requirements to be included in the Liberia Medicines and Health Products Regulatory Authority (LMHRA) clinical trial application package (See Insurance & Compensation)

Sources Added During this Update:

(Document) African Vaccine Regulatory Forum (AVAREF) - Clinical Trial Application Checklist (LBR-1) (Version 2) (October 2019)
African Vaccine Regulatory Forum, World Health Organization

(Webpage) African Vaccine Regulatory Forum (AVAREF) Overview (LBR-4) (Current as of August 18, 2023)
African Vaccine Regulatory Forum, World Health Organization

Sources Revised During this Update:

(Not Available Online) NIAID Communication with the Atlantic Center for Research and Evaluation Institutional Review Board (ACRE IRB) (June 2023) (LBR-28)

(Not Available Online) NIAID Communication with the National Research Ethics Board (NREB) (June 2023) (LBR-38)